• How Veritas Genetics Plans to Make Its $999 Whole Genome Stick

    Bio-IT World | The myGenome service from Veritas Genetics, a $999 screen that includes a whole genome sequence and reports on an expansive number of health conditions, is running up against both the financial and regulatory limits of what genetic testing can offer today.

    Mar 28, 2016

  • AI Hits the Mainstream

    MIT Technology Review | More industries are looking for ways to use artificial intelligence. What will that mean for the technology's future?

    Mar 28, 2016

  • The Quest to Make Synthetic Cells Shows How Little We Know About Life

    The Atlantic | Scientists have created a bacterium with a minimal, life-sustaining genome, but they don't know what a third of its genes do.

    Mar 25, 2016

  • Paul Allen Announces Funding for Research at the Frontiers of Bioengineering and Systems Biology

    Bio-IT World | Paul Allen, the co-founder of Microsoft and a lavish philanthropist in the life sciences, has made a $100 million commitment to a new scientific grant program, the Paul G. Allen Frontiers Group.

    Mar 24, 2016

  • Google's New Stackdriver Service Can Manage Applications Across Multiple Clouds

    Computerworld | Google is aiming to help companies manage their applications running across public and private clouds with a new product and a set of partnerships announced at its cloud user conference.

    Mar 24, 2016

  • Runs in the Family

    The New Yorker | Siddartha Mukherjee, who has a family history of schizophrenia, untangles recent discoveries about the genetic and functional basis of the disease.

    Mar 23, 2016

  • Google's Greene Hastens Cloud Expansion in Race With Amazon

    Bloomberg | Google's new cloud chief Diane Greene had unsettling news for employees at an internal sales meeting this month in Las Vegas: They weren't taking corporate customers seriously enough and needed to sell harder, be hungrier and less complacent.

    Mar 22, 2016

  • No More Peanuts: Merck Pays $20M for Harvard Cancer Drug

    Forbes | Harvard just got $20 million in cash from Merck. Surely, some industry haters will spit out their coffee over that headline. To those in academia who see their endeavor as that of purely noble truth-seekers and educators, striking a lucrative deal with pharma is tantamount to doing business with Tony Soprano.

    Mar 22, 2016

  • Verseon Corp – A New Twist on In Silico Drug Design

    Bio-IT World | For the past decade, a few companies have been pursuing the application of quantum mechanics to the modeling of ligand/receptor interactions. San-Francisco-based Verseon Corporation may have a platform in physics-based computational drug design that could change the economics and the hit quality of drug discovery.

    Mar 17, 2016

  • Startups Begin to Emerge From NYU’s “Virtual” Biotech Factory

    Xconomy | The gap between basic biomedical research and drug development is often called the "valley of death," where promising projects are stymied by a lack of funding. But NYU Langone Medical Center seems poised to bear fruit.

    Mar 17, 2016

  • Apple said to move part of cloud business from AWS to Google

    Computerworld | Apple has moved some of its iCloud business from Amazon Web Services to Google's cloud service, in what is seen as a bid by the iPhone maker to diversify its suppliers.

    Mar 17, 2016

  • Handful of Biologists Went Rogue and Published Directly to Internet

    New York Times | Molecular biologists and neuroscientists are tweeting with the hashtag #ASAPbio in protest of a system that keeps research from being shared with the public, typically for more than six months.

    Mar 16, 2016

  • Bio-IT World Announces Best Practices Finalists

    Bio-IT World | The Editors announced the finalists today in the Bio-IT World Best Practices competition. Entries from 17 groups made it to the final round of competition.

    Mar 15, 2016

  • #BioIT16: A Preview of the Bio-IT World Conference & Expo

    Bio-IT World |The Bio-IT World Conference & Expo comes early this year--April 5-7 in Boston--and yet we are ready to get into the program. Here's a look at some of the sessions we have starred.

    Mar 14, 2016

  • Genetics Database for Autism Free on WuXi NextCODE Exchange

    Bio-IT World News Brief  This morning, the Simons Foundation, a grant-giving institution that supports collaborative efforts in scientific and mathematical research, announced that the Simons Simplex Collection is now open for access by researchers worldwide, through the online WuXi NextCODE Exchange.

    Mar 10, 2016

  • These technologies will blow the lid off data storage

    Computerworld | Data storage manufacturers have repeatedly come up against walls in their quest for ever larger drives and faster performance. And each time, new technology allows them to scale those walls and keep going. They're about to do it again.

    Mar 9, 2016

  • New Chemistry, Basecaller, Prep From Oxford Nanopore

    Bio-IT World Brief | Oxford CTO Clive Brown outlined several updates to the platform in a Google Hangout yesterday including new chemistry, a new basecaller, and changes to library prep, and an update on PromethION.

    Mar 9, 2016

  • Changes at Illumina for Flatley, deSouza, Kahn

    Bio-IT World Brief | Changes at Illumina this week. Today Jay Flatley, current Chairman and CEO, announced he will assume the role of Executive Chairman of the Board of Directors on July 5, 2016. Francis deSouza, currently President, will be appointed President and Chief Executive Officer on the same date and will continue to serve on the Illumina Board of Directors. Scott Khan, Illumina’s Vice President Commercial, Enterprise Informatics, has said he plans to retire from Illumina in early March as well.

    Mar 7, 2016

  • PrecisionFDA Consistency Challenge Will Benchmark the Basic Software Tools of Genetic Research

    Bio-IT World | The first challenge hosted in the FDA's cloud-based precisionFDA platform will score different computational pipelines' ability to accurately call variants from raw DNA sequence data, in a public competition meant to shed light on some of the most essential tools in genomics.

    Mar 4, 2016

  • Alaska’s Biotech Sugar Daddy Is Showering Money on Startups

    Bloomberg.com | Alaska's economic eminence stems from the discovery of oil on the North Slope in the 1960s. But its more recent crown as a biotech sugar daddy started in March 2013 with a chance meeting on a flight from Boston to Seattle.

    Mar 3, 2016